Refine Results
- 必威体育赛事投注
- Applications and Industries
- Content Type
- Analysis Platform
- Language
1 - 20 of 21 results
Applied Filters
必威体育登录手机Cellular-resolution Agilent Seahorse XF bioenergetic analyses were combined with molecular-resolution Agilent Revident Q-TOF LC/MS to investigate adaptations in cancer cells.
必威体育登录手机From analytical to preparative scale, Agilent AdvanceBio Oligonucleotide columns, software, and instrumentation pair seamlessly to minimize method optimization and downtime.
| Japanese (Japan) | Complete (PDF) |
|---|---|
| Korean (Korea) | Complete (PDF) |
| Chinese (Simplified) (China) | Complete (PDF) |
In this application note, Antibody Analytics (Motherwell, UK) integrates IndEx-2, an advanced in vitro cell-based platform engineered to modulate the expression of one or two target antigens across a range of biologically relevant levels, with the...
必威体育登录手机A 45-color spectral flow cytometry panel was designed for the Agilent NovoCyte Opteon spectral flow cytometer to analyze the distribution of immune cells.
| Korean (Korea) | Complete (PDF) |
|---|---|
| Chinese (Simplified) (China) | Complete (PDF) |
| Japanese (Japan) | Complete (PDF) |
In this application note, we explore some of the key parameters when comparing different column chemistries using ion-pair reversed-phase (IP-RP) separation of Semaglutide.
必威体育登录手机Introducing an automated neurite analysis module for Agilent BioTek imaging systems, with iPSC-derived and primary neuron culture model evaluations.
User Guide for SureSelect Cancer CGP Assay and SureSelect Cancer Tumor-specific Assays.
必威体育登录手机The method shown provides an end-to-end solution for low detection limits of quantitation for ASOs in human plasma by combing sample preparation via SPE on an Agilent Bravo liquid handler combined with a standard flow liquid chromatogram coupled...
必威体育登录手机Specification sheet for the Agilent NovoCyte Opteon spectral flow cytometer.Details technical specifications.
必威体育登录手机This flyer provides and overview of the family of Agilent SureSelect Community Designs designed by scientists in the Adam's Group at the Wellcome Sanger Institute.The aim of the research is to understand the genetics of cancer, using a combination...
This poster outlines combining the 3D tumor spheroid invasion model with the RTCA eSight's capability of live cell imaging and automatic quantification of the area of invasive protrusion can facilitate and enhance the development of new treatments...
必威体育登录手机Customize insights for tumor genomic profiling by adding new and emerging biomarkers, including TMB and MSI, with Agilent SureSelect Cancer Custom panels.必威体育登录手机Fast and easy panel design with Agilent SureDesign.
必威体育登录手机This poster reports a novel kinetic immuno-oncology assay using the Agilent xCELLigence RTCA eSight, which can simultaneously and quantitatively assess effector/immune cell clustering and proliferation through brightfield live cell time lapse...
In the present study, we present a simple metabolic preconditioning process that improves T-cell performance and bioenergetics.
This poster presents data that delayed killing of tumor cells in can be resolved using both impedance and imaging on RTCA eSight.
PD-L1 IHC 22C3 pharmDx (SK006) is a qualitative immunohistochemical (IHC) assay using anti-PD-L1, Clone 22C3, to detect PD-L1 in formalin-fixed, paraffin-embedded (FFPE) tumor tissues using the Autostainer Link 48.
This study investigates the impact of Wnt-signaling modulators on mitochondrial dysfunction.It evaluates the effects of selected drug treatments on cellular energy metabolism and cytotoxicity by comparing two distinct breast cancer cell lines: one...
Enhance your targeted omics with a standardized LC/TQ platform.Our advanced LC/TQ technologies allow for the creation of large, multiplexed target lists for primary metabolites, lipids, and peptides.
必威体育登录手机Agilent NovoCyte Opteon 스펙트럼 유세포 분석기의 사양 시트.자세한 기술 사양.
必威体育登录手机Agilent NovoCyte Opteon 光譜流式細胞儀的性能指標表。詳細技術規格。